Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19.

Pepperrell, Toby; Pilkington, Victoria; Owen, Andrew; Wang, Junzheng; Hill, Andrew M

Pepperrell, Toby; Pilkington, Victoria; Owen, Andrew; Wang, Junzheng; Hill, Andrew M.

Pepperrell T; Faculty of Medicine, Imperial College London, UK.
Pilkington V; Imperial College Healthcare NHS Trust.
Owen A; Department of Molecular and Clinical Pharmacology, University of Liverpool, UK.
Wang J; MRC Centre for Drug Safety Science, University of Liverpool, UK.
Hill AM; Faculty of Medicine, Imperial College London, UK.

J Virus Erad ; 6(2): 52-60, 2020 Apr 30.

Article en En | MEDLINE | ID: mdl-32405422

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Systematic_reviews Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Systematic_reviews Idioma: En Año: 2020 Tipo del documento: Article